Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2026-01-02 @ 4:37 AM
Study NCT ID:
NCT00790192
Status:
COMPLETED
Last Update Posted:
2016-03-17
First Post:
2008-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-10
First Submit QC Date:
None
Study First Post Date:
2008-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-01
Results First Submit QC Date:
None
Results First Post Date:
2011-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-11
Last Update Post Date:
2016-03-17
Last Update Post Date Type:
ESTIMATED